Zachary Antovich

CEO at Antogen, Inc

๐Ÿ“ United States๐Ÿ”„ Updated October 2026๐Ÿ’ผ 2 investments๐Ÿ“… 6 years investing๐Ÿ—“ Last invested May 2021
Operator-angel๐ŸŒ United States
2
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

2 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor - Investor
May 2021
Defining the standard for moving information.
Advisor - Investor
Jan 2020
Dahlia Biosciences RNA Flow Assays enable ultra throughput single-cell gene expression analysis.
Experience ยท 3 entries
All (3)
Investments (2)
Founder (1)
2021
Advisor - Investor
May 2021
Defining the standard for moving information.
2020
Advisor - Investor
Jan 2020
Dahlia Biosciences RNA Flow Assays enable ultra throughput single-cell gene expression analysis.
2004
Founder and CEO
Mar 2004
Linkage Biosciences is located in South San Francisco, California. Along with One Lambda, Linkage Biosciences is part of the Transplant Diagnostics Division of Thermo Fisher Scientific, the world leader in serving science. As brands of Thermo Fisher Scientific, Linkage Biosciences and One Lambda are united in our core mission of improving the lives of transplant patients worldwide. Our commitment is to fulfill the needs of the transplant laboratory and advancing the science of transplantation. We accomplish this mission by offering a comprehensive portfolio of HLA typing and antibody detection products on a broad range of technologies including serology, ELISA, flow cytometry, SSP, rSSO, SBT, real-time PCR and NGS. Additionally, we provide laboratory instrumentation, and computer software that are used to simplify and automate testing procedures and final test evaluations.